跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,585 条关于
“Menarini Biotech”
全部
4,585
临床试验
86
药物
766
机构
286
资讯
3,447
去年
ERBC and Menarini Biotech Form Strategic Alliance to Accelerate Biopharmaceutical Development
6个月前
Medidata and Menarini Group Expand AI-Powered Partnership to Accelerate Oncology Clinical Trials
3个月前
Menarini Group to Present Comprehensive Oncology Data at ASCO 2026, Featuring Elacestrant Combination Studies
上个月
Menarini Asia-Pacific to Commercialise Cosela (trilaciclib) Across Multiple APAC Markets, First Launch Anticipated in Hong Kong in 2028
9个月前
Menarini Group to Present New ELZONRIS Data at ASH 2025, Including Promising Triplet Therapy Results for BPDCN
去年
NewAmsterdam's Obicetrapib Receives EMA Validation for European Review Following Positive Phase 3 Results
去年
First Patient Dosed in Phase II JASPIS-01 Trial of Dapolsertib for Relapsed/Refractory DLBCL
去年
GenScript Biotech and NSG Bio Form Strategic Partnership to Accelerate Biotech Innovation in Singapore
去年
BPGbio Named 2024 BioTech AI Company of the Year for AI-Driven Drug Discovery
去年
NHS Rejects Elacestrant (Korserdu) for Advanced Breast Cancer with ESR1 Mutation
第 1 页,共 345 页
上一页
下一页